CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia.
Pratyusha GudapatiTwinkle KhankaGaurav ChatterjeeSitaram GhogaleYajamanam BadrinathNilesh DeshpandeJagruti PatilGaurav NarulaDhanalaxmi ShettyShripad BanavaliNikhil V PatkarSumeet GujralPapagudi G SubramanianPrashant Ramesh TembharePublished in: Cytometry. Part B, Clinical cytometry (2020)
CD304 is commonly expressed in leukemic blasts of BCP-ALL. It is very useful in distinguishing residual disease from hematogones and is a fairly dependable marker. Hence, it is a valuable addition for enhancing the sensitivity and applicability of MFC-based MRD assay in BCP-ALL.